BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20519638)

  • 1. The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity?
    Kulkarni RR; Haeryfar SM; Sharif S
    J Leukoc Biol; 2010 Oct; 88(4):635-43. PubMed ID: 20519638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer T cells within the liver: conductors of the hepatic immune orchestra.
    Swain MG
    Dig Dis; 2010; 28(1):7-13. PubMed ID: 20460885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
    Wu L; Gabriel CL; Parekh VV; Van Kaer L
    Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iNKT cells in microbial immunity: recognition of microbial glycolipids.
    Kinjo Y; Ueno K
    Microbiol Immunol; 2011 Jul; 55(7):472-82. PubMed ID: 21434991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of marginal zone B lymphocytes in invariant NKT cell activation.
    Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
    J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
    Cohen NR; Garg S; Brenner MB
    Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKT cell responses to glycolipid activation.
    Tefit JN; Davies G; Serra V
    Methods Mol Biol; 2010; 626():149-67. PubMed ID: 20099127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKT cells: friend or foe during viral infections?
    Diana J; Lehuen A
    Eur J Immunol; 2009 Dec; 39(12):3283-91. PubMed ID: 19830742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides.
    Paget C; Bialecki E; Fontaine J; Vendeville C; Mallevaey T; Faveeuw C; Trottein F
    J Immunol; 2009 Feb; 182(4):1846-53. PubMed ID: 19201836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
    Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
    J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoke alters the invariant natural killer T cell function and may inhibit anti-tumor responses.
    Hogan AE; Corrigan MA; O'Reilly V; Gaoatswe G; O'Connell J; Doherty DG; Lynch L; O'Shea D
    Clin Immunol; 2011 Sep; 140(3):229-35. PubMed ID: 21684213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
    Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
    Front Immunol; 2018; 9():1266. PubMed ID: 29928278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the behavior of invariant NKT cells in autoimmune diseases.
    Yamamura T; Sakuishi K; Illés Z; Miyake S
    J Neuroimmunol; 2007 Nov; 191(1-2):8-15. PubMed ID: 17905445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.
    Lynch L; O'Shea D; Winter DC; Geoghegan J; Doherty DG; O'Farrelly C
    Eur J Immunol; 2009 Jul; 39(7):1893-901. PubMed ID: 19585513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
    Bricard G; Cesson V; Devevre E; Bouzourene H; Barbey C; Rufer N; Im JS; Alves PM; Martinet O; Halkic N; Cerottini JC; Romero P; Porcelli SA; Macdonald HR; Speiser DE
    J Immunol; 2009 Apr; 182(8):5140-51. PubMed ID: 19342695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection.
    Joyee AG; Uzonna J; Yang X
    J Immunol; 2010 Feb; 184(4):2095-106. PubMed ID: 20089704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.
    Taniguchi M; Tashiro T; Dashtsoodol N; Hongo N; Watarai H
    Int Immunol; 2010 Jan; 22(1):1-6. PubMed ID: 19858073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human non-invariant NKT lymphocytes in the maintenance of type 2 T helper environment during pregnancy.
    Uemura Y; Suzuki M; Liu TY; Narita Y; Hirata S; Ohyama H; Ishihara O; Matsushita S
    Int Immunol; 2008 Mar; 20(3):405-12. PubMed ID: 18234691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.
    Molling JW; Moreno M; van der Vliet HJ; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
    J Immunol Methods; 2007 Apr; 322(1-2):70-81. PubMed ID: 17343874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.